Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

L-Asparaginase

EU orphan designation number: EU/3/04/258   
Active ingredient: L-Asparaginase
Indication: Treatment of acute lymphoblastic leukaemia
Sponsor: medac Gesellschaft für klinische Spezialpräparate mbH
Fehlandtstraße 3, D-20354 Hamburg, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/01/2005 Centralised Orphan - Designation EMEA/OD/063/04 (2005)236 of 26/01/2005